Study On The Application Of A Combined Chinese And Western Medicine Chronic Disease Management Model In CAG Patients

Objective: The model of combined Chinese and Western medicine chronic disease management was applied to the health management of CAG patients.By comparing their clinical symptoms,TCM symptoms,lifestyle,self-management ability,gastroscopic atrophy grades and pathological grades before and after management,we evaluated the effect of this model in CAG patients,and explored the chronic disease management model of Chinese and Western medicine suitable for CAG patients,in order to provide a new method to effectively prevent the occurrence of pregastric cancer.Methods:1.One hundred patients who met the acceptance criteria and attended a hospital from January 2021 to March 2022 were enrolled in the study and randomly divided into a test team and a control team of 50 patients each.2.Using the Health Management Assessment Form to assess patients’ health status and cancer risk,while the control group was adopted the Western Medical Management Plan(W Plan),including health education,Western medicine treatment,and endoscopic follow-up,the experimental group was adopted the Chinese and Western Medical Management Plan(W+T Plan),that is,adding Chinese medical health management to the control group,including the popularization of basic knowledge of Chinese medicine,symptomatic treatment,Chinese medicine characteristic exercise guidance,and Chinese medicine psychotherapy.Follow up and manage Patients in both groups.3.After 9 months of management,the efficacy of the combined Chinese and Western medicine chronic disease management model on CAG patients was evaluated by assessing modifications in related indicators(including clinical symptoms,Chinese medical evidence,lifestyle,self-management ability,gastroscopic atrophy score,and pathological score)before and after health administration and between divergent groups after health treatment in both groups.Results:1.Comparison of baseline data: There was no substantial variation before regulation between the test band and the controlled team in sexual orientation,age,education,payment method,medical burden,complications,distribution of TCM syndrome and other general data(P>0.05).2.Comparison of clinical symptom scores and therapeutic effect : After 9months of administration,the outcomes of clinical symptoms including chest pain,stomach distension,acid reflux and heartbeat in the two groups were less significant than those before administration(P < 0.05).Total clinical symptom scores in the control team were dramatically lower than those in the comparison group(P<0.05).The overall efficacy level was 97.87 % in the experimental team and 89.36 % in the controlling group(P<0.05).3.Comparison of TCM syndrome test scores and curative effect : After 9months of therapy,TCM syndrome results in the two communities were lower than those before administration(P < 0.05).Total TCM syndromes scores in the trial team were noticeably lower than in the contrast group(P<0.05).The total effective rate was 97.87 % in the test category and 83.33 % in the comparison panel(P<0.05).4.Comparison of lifestyle scores : Comparison of individual lifestyle score comparison : After 9 months of managing,diet,smoking,drinking and exercise scores in both organizations were higher than those before treatment(P < 0.05).Results of the experimental team were better than those of the controlled party in both diet and exercise(P<0.05).There was no discernible variation between the two parties in smoking and drinking(P<0.05).After 9months of supervision,the combined lifestyle outcomes in two groups were higher than before administration(P<0.05).Overall lifestyle results in the test party were substantially higher than those in the contrast set(P<0.05).5.Comparison of self-management capability scores : After 9 months of managing,the single points of five dimensions of cognitive ability,psychological status,behavior pattern,social environment,and therapy compliance and aggregate self-management ability grades of the two categories were higher than those before administration(P<0.05).In contrast with the comparison group,the increase in personal scores and aggregate scores in the study area was markedly higher than that in the contrast panel(P<0.05).6.Comparison of gastroscopy efficacy : After 9 months of operation,the severity of intestinal mucosal atrophy in both populations was less severe than before control(P<0.05).In comparison to the control group,the trial party was stronger than the controlled one in raising the shrinkage level(P<0.05).7.Comparison of pathological efficacy : After 9 months,intestinal metaplasia,chronicitis,contracture,and colon metaplasia of gastric mucosa in both parties were enhanced in comparison to those before administration(P<0.05).The trial group outperformed the control team in improving inflamed mobility,long-term inflammation,shrinkage,and colon metaplasia of gastric mucosa(P<0.05).There was no substantial change in the enhancement of acute contraction and intense intestine metastasia between the two categories(P>0.05).8.Safety comparison : No severe detrimental events took place in both teams during the administration process.Conclusion(s):1.Compared with the simple western medicine administration mode,the integrated Chinese and Western medicine CDM approach can successfully reduce clinical symptoms and TCM syndromes in CAG patients,such as upper abdominal pain,abdominal distension,acid reflux,and heartburn.2.The integrated Chinese and Western medicine CDM model can help CAG patients improve their lifestyle and self-management skills to reach the target of significant illness preparedness and regulation.3.The combined Chinese and western medicine CDM model can decrease the grading degree of gastroscopic atrophy of CAGpatients,drastically ameliorate the pathological state of their gastric mucosal inflammatory activity,degree of inflammation,mild to moderate atrophy and gutization,and have no discernible effects on their severe atrophy and gutization.